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Mutations in PTEN-induced putative kinase 1 (PINK1) cause recessive form of Parkinson’s disease
(PD). PINK1 acts upstream of parkin, regulating mitochondrial integrity and functions. Here, we
show that PINK1 in combination with parkin results in the perinuclear mitochondrial aggregation
followed by their elimination. This elimination is reduced in cells expressing PINK1 mutants with
wild-type parkin. Although wild-type PINK1 localizes in aggregated mitochondria, PINK1 mutants
localization remains diffuse and mitochondrial elimination is not observed. This phenomenon is
not observed in autophagy-deﬁcient cells. These results suggest that mitophagy controlled by the
PINK1/parkin pathway might be associated with PD pathogenesis.
Structured summary:
MINT-7557195: PINK1 (uniprotkb:Q9BXM7) physically interacts (MI:0915) with LC3 (uniprotkb:Q9GZQ8)
by anti tag coimmunoprecipitation (MI:0007)
MINT-7557109: LC3 (uniprotkb:Q9GZQ8) and PINK1 (uniprotkb:Q9BXM7) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7557121: tom20 (uniprotkb:Q15388) and PINK1 (uniprotkb:Q9BXM7) colocalize (MI:0403) by ﬂuo-
rescence microscopy (MI:0416)
MINT-7557138: parkin (uniprotkb:O60260), PINK1 (uniprotkb:Q9BXM7) and tom20 (uniprotkb:Q15388)
colocalize (MI:0403) by ﬂuorescence microscopy (MI:0416)
MINT-7557173: LC3 (uniprotkb:Q9GZQ8) physically interacts (MI:0915) with PINK1 (uniprotkb:Q9BXM7)
by anti bait coimmunoprecipitation (MI:0006)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Parkinson’s disease (PD) is a neurodegenerative disease charac-
terized by loss of dopaminergic neurons in the substantia nigra.
Mitochondrial dysfunction has been proposed as a major factor in
the pathogenesis of sporadic and familial PD [1. In particular, the
identiﬁcation ofmutations in PTEN-induced putative kinase 1 (PINK1)
has strongly implicatedmitochondrial dysfunction in the pathogen-chemical Societies. Published by E
phenylhydrazone; 3-MA, 3-
MTS, mitochondrial targeting
ced putative kinase 1; UPS,
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i).esis of PD [2]. PINK1 contains anN-terminalmitochondrial targeting
sequence (MTS) and a serine/threonine kinase domain [2].
Several studies have shown that PINK1 acts upstreamof parkin in
the same genetic pathway [3,4]. Overexpression of PINK1 promotes
mitochondrial ﬁssion [5]. Fission followed by selective fusion segre-
gates dysfunctional mitochondria and permits their removal by
autophagy [6]. Parkin is associated with mitochondrial elimination
in cultured cells treated with themitochondrial uncoupler carbonyl
cyanide m-chlorophenylhydrazone (CCCP) [7], but little is known
about the biological function of PINK1 in this context. Likewise,
although co-overexpressed both PINK1 and parkin colocalized with
mitochondria [8] and are associated with mitochondrial autophagy
(mitophagy) [9], the exactmechanismof themitochondrial elimina-
tion via autophagy has not been examined.
Here, we describe the characterization of mitophagy induced by
co-overexpressing both proteins and report that the phenomenon is
dependent on PINK1 kinase activity andmitochondrial localization.lsevier B.V. All rights reserved.
1074 S. Kawajiri et al. / FEBS Letters 584 (2010) 1073–1079Furthermore, we found that PINK1 interactswith LC3–phospholipid
conjugate (LC3-II), a well established marker for autophagosomes
[10]. These results provide novel insights into the pathogenesis of
PD.
2. Materials and methods
2.1. Antibodies
Anti-FLAG antibodies (M2, polyclonal) and anti-LC3B antibody
(rabbit) were obtained from Sigma. Anti-actin antibody (mouse)
was from Millipore. Anti-Tom20 antibody (rabbit) was from Santa
Cruz Biotechnology. Anti-LDH antibody (goat) was from Abcam.
Anti-LC3 antibody (rabbit) was from MBL. Secondary antibodies,
conjugated to horseradish peroxidase, were from GE HealthCare
Bio-Sciences and Alexa Fluor 488, 546, 594, and 647 conjugated
secondary antibodies were from Invitrogen-Molecular Probes.Fig. 1. PINK1 is degraded by autophagy as well as by the ubiquitin–proteasome system.
untreated with E64d (10 lg/ml) + pepstatin A (10 lg/ml) or lactacystin (10 lM) (A
immunoblotting with anti-FLAG antibodies (M2). The bottom panels show actin as loadin
of at least three experiments. (D) Immunocytochemistry of HeLa cells transiently overe
respectively. The boxed area is shown in the bottom image at a higher magniﬁcation. B2.2. Plasmids
A cDNA encoding wild-type PINK1 was ampliﬁed with appro-
priate primers and ligated into the BamHI sites of the (C-terminal
tagged) 3xFLAG pCMV-10™ expression plasmid (Sigma). Muta-
tions in PINK1 were introduced by site-directed mutagenesis
(Stratagene) according to manufacturer’s instructions. GFP-parkin
was subcloned into pcDNA3.1 (Invitrogen).
2.3. Cell culture
HeLa, HEK293 cells and Atg7+/+ and /mouse embryonic ﬁbro-
blasts (MEFs) (a gift from Dr. Komatsu) were grown in DMEM (Sig-
ma) supplemented with 10% FBS (Sigma) and 1% penicillin–
streptomycin (Invitrogen) at 37 C and 5% CO2. For pharmacologi-
cal studies, E64d, pepstatin A, rapamycin, 3-MA, and CCCP (Sigma)
were added at indicated times and concentrations.(A and B) PINK1 levels in HEK293 cells stably expressing PINK1-3xFLAG treated or
), and 3-MA (10 mM) or rapamycin (200 nM) (B), for 24 h were analyzed by
g control. (C) Quantiﬁcation of (B); *P < 0.05. Error bars indicate standard deviation
xpressing PINK1-3xFLAG, 24 h after transfection. PINK1 or LC3 are in red or green,
ars, 10 lM.
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Cells were transfected with the indicated plasmids using Lipo-
fectamine 2000 (Invitrogen) and Lipofectamine LTX with PLUS Re-
agent (Invitrogen) according to manufacturer’s instructions. For
stable overexpression of PINK1, HEK293 cells were transfected
with PINK1 plasmids and then selected using G418.
2.5. Immunocytochemistry
Cells were ﬁxed with 4% paraformaldehyde, permeabilized with
1 PBS containing 0.5% Triton X-100, and incubated in PBS con-
taining 10% FBS and 1% BSA. Cells were then incubated overnight
with primary antibodies, followed by incubation with secondary
antibodies for 1 h. Cells were then mounted with Vectashield con-
taining DAPI (Vector Laboratories). Cells were visualized using a
ZEISS LSM510 confocal microscope.
2.6. Cell fractionation
Cells were fractionated using the mitochondrial isolation kit for
cultured cells (Pierce) according to manufacturer’s instructions.Fig. 2. PINK1 is recruited to depolarized mitochondria. (A) Immunocytochemistry of HEK
3 h. PINK1 or Tom20 are in green or red, respectively. Bars, 10 lM. (B) HEK293 cells sta
(10 lM) for 3 h were fractionated and immunoblotted for FLAG, Tom20, and LDH. (C)
deviation of at least three experiments.2.7. Immunoprecipitation and immunoblotting
Cells were lysed on ice in lysis buffer [10 mM Tris–HCl (pH 7.5),
150 mM NaCl, 1 mM EDTA, 1% NP-40, and protease inhibitors
(complete, Mini, EDTA-free, (Roche Applied Science))]. Cell lysates
were immunoprecipitated using Dynabeads protein G (Invitrogen)
according to manufacturer’s instructions and immunoblotting was
performed previously described elsewhere [11].
3. Results and discussion
3.1. PINK1 is degraded by autophagy as well as by the ubiquitin–
proteasome system (UPS)
Previous studies have shown that PINK1 is degraded by the UPS
[12], but it remains unclear whether autophagy also affects its deg-
radation. We, therefore, tested whether PINK1 could be degraded
via the UPS and/or autophagy, using HEK293 cells stably express-
ing PINK1-3xFLAG. Immunoblot analysis identiﬁes PINK1 in two
bands. The upper band represents full-length PINK1 (66 kDa),
whereas the lower band represents the mature form of PINK1
(55 kDa), in which the MTS has been removed [13,14]. As others293 cells stably expressing PINK1-3xFLAG treated with DMSO or CCCP (10 lM) for
bly expressing 3xFLAG-empty vector or PINK1-3xFLAG treated with DMSO or CCCP
Quantiﬁcation of (B); *P < 0.05. NS, non-signiﬁcant. Error bars indicate standard
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treatment with a proteasome inhibitor (lactacystin) (Fig. 1A). Also,
they were increased by lysosome protease inhibitors (E64d + pep-
statin A), which block autophagic ﬂux (Fig. 1A). Next, we investi-
gated the effects of other autophagy modulators (rapamycin and
3-methyladenine (3-MA)) on levels of PINK1. As expected, rapamy-
cin treatment decreased mature form PINK1 levels, although 3-MA
treatment increased them (Fig. 1B and C). Immunocytochemistry
of HeLa cells transiently overexpressing PINK1-3xFLAG demon-
strated partial colocalization of PINK1 with endogenous LC3 (an
autophagosomal marker) (Fig. 1D). These data suggested that
PINK1 is degraded via autophagy as well as by the UPS.
3.2. PINK1 is recruited to depolarized mitochondria
In cultured cells treated with CCCP, parkin is selectively re-
cruited to degraded mitochondria and promotes mitophagy [7].
PINK1 and parkin function in the same genetic pathway to regulate
mitochondrial integrity [3,4]. To investigate the interaction be-
tween depolarized mitochondria and PINK1, we tested for a change
of PINK1 localization following treatment with CCCP. In HEK293
cells stably expressing PINK1, mitochondria stained with antibody
against Tom20, a receptor protein of the mitochondrial outer mem-
brane, were aggregated around the nucleus and fragmented and
showed marked accumulation of PINK1 (Fig. 2A). The mitochon-
drial translocation of PINK1, caused by CCCP, was also assayed by
immunoblotting. Levels of full-length PINK1 in the mitochondrial
fraction were increased by CCCP treatment (Fig. 2B and C).
3.3. Mitochondrial elimination is accomplished by overexpression of
wild-type PINK1 in combination with parkin
PINK1hasbeenreportedtopromoteparkin translocation tomito-
chondria [8]. To further investigate the molecular interaction be-
tween PINK1 and parkin, the following experiments with HeLa
cells overexpressing both PINK1 and parkin were performed.
Twenty-four hours after transfection, mitochondrial aggregation
andrecruitmentofPINK1andparkin to theaggregatedmitochondriaFig. 3. Mitochondrial elimination is accomplished by overexpression of wild-type PINK1
transient co-overexpression of wild-type PINK1-3xFLAG (PINK1-WT) and GFP-empty vec
WT and GFP-parkin (C). Tom20, wild-type PINK1, or GFP are red, white, or green, respewere observed only in cells positive for GFP-parkin and PINK1-
3xFLAG. Moreover, parkin completely colocalized with aggregated
mitochondria (Fig. 3A and B). Partial colocalization of wild-type
PINK1withparkinhasbeenpreviously reported incellsoverexpress-
ingbothPINK1andparkin; however, the associationwithmitochon-
driawasnotexamined[15].Also, parkincolocalizationwithPINK1 in
aggregated mitochondria has been previously reported [8]. To con-
ﬁrm the exact effect of both PINK1 and parkin on mitochondria, we
examined the fate of thedegradedmitochondria, 48 h after transfec-
tion. In cells overexpressing both PINK1 and parkin, the mitochon-
dria were completely absent, while mitochondria were still present
in cells overexpressing either PINK1 or parkin (Fig. 3C). These data
indicate thatbothPINK1andparkinmightbe indispensable formito-
chondrial elimination.
3.4. PINK1 mutants remain diffusely distributed and are not recruited
to mitochondria, resulting in reduced mitochondrial elimination
PD-associated mutations in PINK1 have been found in both the
kinase and C-terminal domains [2,16]. Among these mutations,
G309D, L347P, and G409V are expected to cause a reduction in
the kinase activity of PINK1 [13,14,17]. Therefore, we generated
PINK1 mutants with G309D, L347P and G409V and two deletion
mutants without the MTS (DN: deleted amino acids 156–581 and
KD: deleted amino acids 156–509) and performed similar transfec-
tion experiments to those described above. Neither recruitment of
parkin and/or mutant PINK1 to the mitochondria nor mitochon-
drial aggregation was detected 24 h after transfection (data not
shown). Forty-eight hours after transfection, the G309D/L347P/
G409V mutants preserved their mitochondrial localization, whilst
less mitochondrial elimination was detected compared with those
cells expressing both wild-type PINK1 and parkin. The DN/KD mu-
tants were diffusely distributed without apparent colocalization to
the mitochondria and no mitochondrial elimination was observed
(Fig. 4A–C). Also, we conﬁrmed mitochondrial elimination by
immunoblotting. Levels of Tom20 were decreased in cells express-
ing both parkin and wild-type PINK1 but not in the cells expressing
PINK1 mutants (Fig. 4D and E). These ﬁndings suggested that thein combination with parkin. (A and B) Immunocytochemistry of HeLa cells 24 h after
tor (GFP) (A) or GFP-parkin (B) and 48 h after transient co-overexpression of PINK1-
ctively. Bars, 10 lm.
Fig. 4. PINK1 mutants remain diffusely distributed and are not recruited to mitochondria, resulting in reduced mitochondrial elimination. (A) Immunocytochemistry of HeLa
cells transiently overexpressing GFP-empty vector and PINK1-3xFLAG (WT) as control, and GFP-parkin and PINK1-3xFLAG (WT or various mutants), 48 h after transfection.
Tom20, WT and PINK1 mutants, or GFP are in red, white, or green, respectively. Bars, 10 lm. (B and C) Ratio of cells with undegraded mitochondria to total cells positive for
both GFP and FLAG, 24 h (B) and 48 h (C) after transfection are shown in the graph. (D) Levels of Tom20 in HeLa cells transiently overexpressing GFP-empty vector and PINK1-
3xFLAG (WT), and GFP-parkin and PINK1-3xFLAG (WT or various mutants) were analyzed with immunoblotting. (E) Quantiﬁcation of (D); error bars indicate standard
deviation of at least three experiments. *P < 0.05, **P < 0.01, ***P < 0.001. NS, non-signiﬁcant.
S. Kawajiri et al. / FEBS Letters 584 (2010) 1073–1079 1077kinase activity and mitochondrial localization of PINK1 are indis-
pensable for mitochondrial elimination.
3.5. Overexpression of wild-type PINK1 in combination with parkin
induces mitophagy
Very recently, it has been reported aggregated mitochondria in
cells overexpressing both PINK1 and parkin colocalize with lyso-
somes as well as autophagosomes [9]. However, the fate of perinu-
clear aggregated mitochondria has not been examined. Therefore,
we checked whether PINK1–parkin dependent mitochondrialelimination was dependent on mitophagy. Mitochondrial elimina-
tion was enhanced by overexpression of PINK1 with parkin in wild-
type MEFs. On the other hand, Atg7/ MEFs, which lack a key
component of the autophagy system, retain expression of Tom20
(Fig. 5A and B). To further analyze this hypothesis, we examined
the change of endogenous LC3 distribution following both PINK1
and parkin overexpression. We conﬁrmed accumulation of parkin,
which overlaps with aggregated mitochondria (refer to Fig. 3), in
cells expressing both wild-type proteins. Likewise, endogenous
LC3 mainly colocalized with wild-type PINK1, adjoined to the outer
mitochondrial membrane, but did not colocalize with G409V orDN
Fig. 5. Overexpression of wild-type PINK1 in combination with parkin induces mitophagy. (A) Levels of Tom20 in Atg7+/+ MEFs overexpressing GFP-empty vector and PINK1-
3xFLAG and those in Atg7+/+ and Atg7/MEFs overexpressing GFP-parkin and PINK1-3xFLAG, 48 h after transfection were analyzed by immunoblotting. (B) Quantiﬁcation of
(A); error bars indicate standard deviation of at least three experiments. *P < 0.05, **P < 0.01, NS, non-signiﬁcant. (C) Immunocytochemistry of HeLa cells transiently
overexpressing GFP-parkin and PINK1-3xFLAG (wild-type, G409V, and DN), 24 h after transfection. PINK1 (WT and mutants), LC3, or GFP-parkin are in white, red, or green,
respectively. The boxed areas are shown in the three right-hand images at a higher magniﬁcation. Bars, 10 lm. (D and E) HeLa cells overexpressing 3xFLAG-empty vector and
GFP-empty vector, PINK1-3xFLAG and GFP-empty vector, or PINK1-3xFLAG and GFP-parkin, 24 h after transfection were immunoprecipitated with anti-LC3 antibodies (D) or
anti-FLAG antibodies (E) and immunoblotted for FLAG or LC3. Immunoblotting of total lysates was performed to test the expression levels. IP, immunoprecipitation.
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partially colocalized with parkin. Compared with Fig. 1D, the colo-
calization of endogenous LC3 with PINK1 was markedly enhanced.
Next, to investigate direct interaction, cell lysates were immuno-
precipitated using anti-LC3 antibodies and immunoblotted with
anti-FLAG antibodies (Fig. 5D). The reverse immunoprecipitationwas also performed (Fig. 5E). These results allowed us to conclude
that PINK1 binds with LC3-II. Taken together, we concluded that
mitochondrial elimination by the PINK1–parkin pathway is depen-
dent on mitochondrial autophagic activity.
In this study, we have found that overexpression of both
proteins enhances mitochondrial elimination via autophagy. In
S. Kawajiri et al. / FEBS Letters 584 (2010) 1073–1079 1079contrast to the results of a Drosophila study, a PINK1–parkin path-
way promotes mitochondrial enlargement or aggregation in mam-
malian cellular models [8,18]. However, only PINK1 overexpressing
cells exhibit longer mitochondria with increased interconnectivity,
but the abnormal mitochondria do not elicit an autophagic re-
sponse [12]. Consistent with this, wild-type PINK1 overexpression
did not change the level of endogenous LC3-II (data not shown).
Therefore, coordinating activation of parkin and PINK1 contributes
to mitophagy.
PINK1 localization in mitochondria is dependent on its MTS re-
gion and it exhibits autophosphorylation activity in vitro [2,13,14].
Parkin is recognized as an in vivo substrate of PINK1 and parkin
site-direct phosphorylation by wild-type PINK1 is critical for the
translocation of parkin into the mitochondria in cellular and Dro-
sophila models [8]. In agreement with this report, our study
showed that parkin recruitment to the mitochondria by PINK1
was dependent on PINK1 kinase activity.
Silencing of PINK1 with shRNA increased mitochondrial ﬁssion
and induced mitophagy [12]. Although PINK1 overexpression is
protective against oxidative stress-induced apoptotic cell death
[2,19,20], excess wild-type PINK1 without parkin overexpression
does not elicit mitochondrial autophagy [12]. Our immunocyto-
chemical experiments revealed that PINK1 co-overexpressed with
parkin colocalized mainly with LC3-positive vesicles and partially
with perinuclear aggregated mitochondria, which were expected
to colocalize with aggregated parkin. In addition, molecular bind-
ing between PINK1 and LC3-II was conﬁrmed by immunoprecipita-
tion, which suggests that association between PINK1 and LC3
contribute to mitophagy. Combined with the observation by
Vives-Bausa et al., although it is not clear whether an excess of
mitophagy would be harmful to cells, a PINK1–parkin pathway,
which is regulated by kinase activity and/or the mitochondrial
localization of PINK1, would control mitochondrial maintenance
via the autophagic machinery.
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